StonvexLoading…
StonvexStonvexStonvexCore line items from UPBD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.19B | $1.22B | $4.70B | $3.50B | $2.33B |
Operating Income | Not available | $77.44M | $223.35M | $166.10M | $113.35M |
Net Income | Not available | $35.79M | $73.24M | $53.50M | $15.48M |
EPS (Diluted) | $1.07 | $0.61 | $1.25 | $0.91 | $0.69 |
Total Assets | Not available | $3.13B | $3.28B | $3.21B | $3.10B |
Total Liabilities | Not available | $2.41B | $2.58B | $2.52B | $2.41B |
Cash & Equivalents | Not available | $98.41M | $120.53M | $107.02M | $106.84M |
Free Cash Flow OCF − CapEx | Not available | $154.70M | $238.71M | $214.66M | $116.73M |
Shares Outstanding | Not available | 58.85M | 58.61M | 58.64M | 58.51M |